RZH
GILD icon

Relyea Zuckerberg Hanson’s Gilead Sciences GILD Stock Holding History

Relyea Zuckerberg Hanson’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Sell
3,176
-34
-1% -$4.48K 0.03% 211
2026
Q1 		$447K Sell
3,210
-40
-1% -$5.6K 0.05% 170
2025
Q4 		$399K Buy
3,250
+202
+7% +$24.5K 0.04% 187
2025
Q3 		$338K Buy
3,048
+12
+0.4% +$1.36K 0.04% 200
2025
Q2 		$337K Sell
3,036
-37
-1% -$3.94K 0.04% 200
2025
Q1 		$344K Buy
3,073
+66
+2% +$6.81K 0.05% 189
2024
Q4 		$278K Buy
3,007
+437
+17% +$39.3K 0.04% 218
2024
Q3 		$215K Buy
+2,570
New +$196K 0.03% 237
2024
Q2 		– Sell
-3,352
Closed -$246K – 240
2024
Q1 		$246K Sell
3,352
-35
-1% -$2.69K 0.04% 205
2023
Q4 		$274K Buy
3,387
+533
+19% +$41.5K 0.05% 174
2023
Q3 		$214K Buy
2,854
+165
+6% +$12.7K 0.05% 181
2023
Q2 		$207K Buy
+2,689
New +$214K 0.05% 185

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Relyea Zuckerberg Hanson's GILD Position: Q2 2026 in Review

Relyea Zuckerberg Hanson reduced its Gilead Sciences (GILD) stake by 1.1% in Q2 2026, selling an estimated $4.48K and leaving 3,176 shares worth $401K. The position accounts for 0.03% of the portfolio, ranked #211.

Relyea Zuckerberg Hanson first reported a position in GILD in Q2 2023 and has held it in 12 quarters since. The position peaked at $447K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Relyea Zuckerberg Hanson held 3,176 shares of Gilead Sciences worth $401K as of Q2 2026.
  • Relyea Zuckerberg Hanson sold 34 Gilead Sciences shares in Q2 2026, an estimated $4.48K.
  • Gilead Sciences made up 0.03% of Relyea Zuckerberg Hanson's portfolio in Q2 2026, its #211 holding.
  • Relyea Zuckerberg Hanson first reported a position in Gilead Sciences in Q2 2023 and has held it in 12 quarters since.
  • Relyea Zuckerberg Hanson's Gilead Sciences position peaked at $447K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Relyea Zuckerberg Hanson's 13F filing for Q2 2026, filed 16 Jul 2026.